其它别名3-{3,5-Dimethyl-4-[3-(3-Methylisoxazol-5-yl)Propoxy]Phenyl}-5-(Trifluoromethyl)-1,2,4-Oxadiazole; Pleconaril3-{3,5-Dimethyl-4-[3-(3-Methyl-Isoxazol-5-yl)-Propoxy]-Phenyl}-5-Trifluoromethyl-[1,2,4]Oxadiazole; To
N-Hydroxy-3,5-Dimethyl-4-<<3-(3-Methyl-5-Isoxazolyl)Propyl>Oxy>Benzenecarboxamide Imine 反应生成普可那利 参考文献:1,2,4-Oxadiazolyl-Phenoxyalkylisoxazoles And Their Use As Antiviral 标题:1,2,4-Oxadiazolyl-Phenoxyalkylisoxazoles And Their Use As Antiviral 摘要:式为##str1##的化合物,其中:R.Sub.1是烷基,烷氧基,羟基,环烷基,羟基烷基,烷氧基烷基或羟基烷氧基;Y是3至9个碳原子的脂肪基;R.Sub.2和r.Sub.3独立地是氢,烷基,烷氧基,卤素,三氟甲基和硝基;R.Sub.4是烷氧基,羟基,卤代甲基,二卤代甲基,三卤代甲基,环烷基,烷氧羰基,羟基烷基,烷氧基烷基,烷基羧酸酯氧基烷基,氰基,2,2,2-三氟乙基,(4-甲基苯基)磺酰氧甲基,N.Dbd.Q或con.Dbd.Q,其中n.Dbd.Q是氨基,烷基氨基或二烷基氨基;或其药学上可接受的酸加成盐可用作抗病毒剂.
专利号:US-2016185745-A1 优先权日:2013-08-07 标题:Analogs of vinaxanthone and xanthofulvin, methods of synthesis, and methods of treatments thereof 发明人:SIEGEL DIONICIO; CHIN MATTHEW; ELIASEN ANDERS; AXELROD ABRAM 权利人:UNIV TEXAS 摘要:The present invention relates generally to methods of synthesis of vinaxanthone and xanthofulvin, novel analogs, and methods of use thereof.
专利号:WO-9964032-A1 优先权日:1998-06-08 标题 :Combinatorial synthesis of multibinding libraries 发明人:CHRISTENSEN BURTON G; GRIFFIN JOHN H; JENKINS THOMAS E; JUDICE J KEVIN 权利人:ADVANCED MEDICINE INC; CHRISTENSEN BURTON G; GRIFFIN JOHN H; JENKINS THOMAS E; JUDICE J KEVIN 摘要:Disclosed are methods for synthesizing large collections of diverse multimeric compounds as well as iterative processes for evaluating key molecular constraints imparting multibinding properties to multimeric compounds. Also disclosed are libraries of multimeric compounds which can be evaluated for imparting multibinding properties.
专利号:US-9994558-B2 优先权日:2013-09-20 标题 :Multicyclic compounds and methods of using same 发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON 权利人:KARYOPHARM THERAPEUTICS INC 摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).
专利号:US-10736911-B2 优先权日:2015-12-29 标题 :Use of a DHODH inhibitor in combination with an inhibitor of pyrimidine salvage 发明人:DEANS RICHARD; OKESLI AYSE; MORGENS DAVID; KHOSLA CHAITAN; BASSIK MICHAEL C 权利人:UNIV LELAND STANFORD JUNIOR 摘要:Compounds and methods are provided for the treatment of pathogenic virus infections or cancer. The formulations combine an inhibitor of de novo pyrimidine synthesis, and an inhibitor of a pyrimidine salvage pathway enzyme.
专利号:US-10065924-B2 优先权日:2014-07-22 标 题 :Preparation and biological evaluation of viridicatumtoxin analogs 发明人:NICOLAOU KYRIACOS C; HALE CHRISTOPHER R H; NILEWSKI CHRISTIAN; IOANNIDOU HERAKLIDIA; EL MARROUNI ABDELLATIF 权利人:UNIV RICE WILLIAM M 摘要:In one aspect, the present invention provides novel derivatives of viridicatumtoxin of the formula wherein the variables are as defined herein. The application also provides compositions, methods of treatment, and methods of synthesis thereof.
1: Billich A. Pleconaril Sanofi Synthélabo/ViroPharma. Curr Opin Investig Drugs. 2000 Nov;1(3):303-7. 29(11):2902-2908. doi: 10.1038/s41591-023-02576-1. Epub 2023 Oct 4. 3: Florea NR, Maglio D, Nicolau DP. Pleconaril, a novel antipicornaviral agent. Pharmacotherapy. 2003 Mar;23(3):339-48. doi: 10.1592/phco.23.3.339.32099. 4: Ianevski A, Frøysa IT, Lysvand H, Calitz C, Smura T, Schjelderup Nilsen HJ, Høyer E, Afset JE, Sridhar A, Wolthers KC, Zusinaite E, Tenson T, Kurg R, Oksenych V, Galabov AS, Stoyanova A, Bjørås M, Kainov DE. The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants. Antiviral Res. 2024 Apr;224:105842. doi: 10.1016/j.antiviral.2024.105842. Epub 2024 Feb 26. 21(1):127. doi: 10.1186/s12887-021-02599-y.
合成参考文献
参考文献:10.1007/s13312-012-0216-0 摘要:Sharma S, Mishra D, Aneja S, Kumar R, Jain A, Vashishtha VM; Expert Group on Encephalitis, Indian Academy of Pediatrics. Consensus guidelines on evaluation and management of suspected acute viral encephalitis in children in India. Indian Pediatr. 2012 Nov;49(11):897–910. doi: 10.1007/s13312-012-0216-0. 参考文献:10.1053/spid.2002.29756 摘要:Sawyer MH. Enterovirus infections: Diagnosis and treatment. Seminars in Pediatric Infectious Diseases. 2002 Jan;13(1):40–7. doi: 10.1053/spid.2002.29756. 参考文献:10.1007/s11908-002-0023-1 摘要:Romero JR. Diagnosis and Management of Enteroviral Infections of the Central Nervous System. Curr Infect Dis Rep. 2002 Aug;4(4):309–16. doi: 10.1007/s11908-002-0023-1. 参考文献:10.1007/s11908-002-0027-x 摘要:Lu HZ, Bloch KC, Tang YW. Molecular Techniques in the Diagnosis of Central Nervous System Infections. Curr Infect Dis Rep. 2002 Aug;4(4):339–50. doi: 10.1007/s11908-002-0027-x. 参考文献:10.1016/s1473-3099(02)00326-2 摘要:The Lancet Infectious Diseases. Cold comfort. The Lancet Infectious Diseases. 2002 Jul;2(7):385. doi: 10.1016/s1473-3099(02)00326-2.